Connection

JOANNA JANKOWSKY to Mice, Transgenic

This is a "connection" page, showing publications JOANNA JANKOWSKY has written about Mice, Transgenic.
Connection Strength

2.534
  1. Practical considerations for choosing a mouse model of Alzheimer's disease. Mol Neurodegener. 2017 12 22; 12(1):89.
    View in: PubMed
    Score: 0.359
  2. TMEM106B coding variant is protective and deletion detrimental in a mouse model of tauopathy. Acta Neuropathol. 2024 Mar 25; 147(1):61.
    View in: PubMed
    Score: 0.138
  3. Doxycycline for transgene control disrupts gut microbiome diversity without compromising acute neuroinflammatory response. J Neuroinflammation. 2024 Jan 04; 21(1):11.
    View in: PubMed
    Score: 0.136
  4. Temporal and spatially controlled APP transgene expression using Cre-dependent alleles. Dis Model Mech. 2022 05 01; 15(5).
    View in: PubMed
    Score: 0.121
  5. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng. 2001 Jun; 17(6):157-65.
    View in: PubMed
    Score: 0.114
  6. Gene therapy using A? variants for amyloid reduction. Mol Ther. 2021 07 07; 29(7):2294-2307.
    View in: PubMed
    Score: 0.112
  7. Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease. Hum Mol Genet. 2019 06 15; 28(12):2014-2029.
    View in: PubMed
    Score: 0.099
  8. Brain-wide distribution of reporter expression in five transgenic tetracycline-transactivator mouse lines. Sci Data. 2019 02 26; 6:190028.
    View in: PubMed
    Score: 0.097
  9. Combination anti-A? treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice. J Exp Med. 2018 05 07; 215(5):1349-1364.
    View in: PubMed
    Score: 0.091
  10. Discrete Pools of Oligomeric Amyloid-? Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis. Am J Pathol. 2018 03; 188(3):739-756.
    View in: PubMed
    Score: 0.090
  11. Neuronal overexpression of human VAPB slows motor impairment and neuromuscular denervation in a mouse model of ALS. Hum Mol Genet. 2016 11 01; 25(21):4661-4673.
    View in: PubMed
    Score: 0.083
  12. Humanized Tau Mice with Regionalized Amyloid Exhibit Behavioral Deficits but No Pathological Interaction. PLoS One. 2016; 11(4):e0153724.
    View in: PubMed
    Score: 0.080
  13. Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex. Brain Struct Funct. 2016 05; 221(4):2231-49.
    View in: PubMed
    Score: 0.074
  14. Impairments in experience-dependent scaling and stability of hippocampal place fields limit spatial learning in a mouse model of Alzheimer's disease. Hippocampus. 2014 Aug; 24(8):963-78.
    View in: PubMed
    Score: 0.070
  15. Specificity and efficiency of reporter expression in adult neural progenitors vary substantially among nestin-CreER(T2) lines. J Comp Neurol. 2014 Apr 01; 522(5):1191-208.
    View in: PubMed
    Score: 0.069
  16. Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease. J Neurosci. 2014 Mar 12; 34(11):3826-40.
    View in: PubMed
    Score: 0.069
  17. Wild-type neural progenitors divide and differentiate normally in an amyloid-rich environment. J Neurosci. 2013 Oct 30; 33(44):17335-41.
    View in: PubMed
    Score: 0.067
  18. Strain background influences neurotoxicity and behavioral abnormalities in mice expressing the tetracycline transactivator. J Neurosci. 2012 Aug 01; 32(31):10574-86.
    View in: PubMed
    Score: 0.062
  19. Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult. Mol Neurodegener. 2012 Jun 18; 7:28.
    View in: PubMed
    Score: 0.061
  20. Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy. J Neurosci. 2011 Mar 16; 31(11):4124-36.
    View in: PubMed
    Score: 0.056
  21. Remote sites of structural atrophy predict later amyloid formation in a mouse model of Alzheimer's disease. Neuroimage. 2010 Apr 01; 50(2):416-27.
    View in: PubMed
    Score: 0.052
  22. Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J Neurosci. 2007 Jun 20; 27(25):6771-80.
    View in: PubMed
    Score: 0.043
  23. Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice. J Biol Chem. 2007 Aug 03; 282(31):22707-20.
    View in: PubMed
    Score: 0.043
  24. Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease. PLoS Med. 2005 Dec; 2(12):e355.
    View in: PubMed
    Score: 0.039
  25. Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci. 2005 May 25; 25(21):5217-24.
    View in: PubMed
    Score: 0.037
  26. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging. 2004 Aug; 25(7):885-92.
    View in: PubMed
    Score: 0.035
  27. Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol. 2003 Dec; 62(12):1220-7.
    View in: PubMed
    Score: 0.034
  28. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet. 2004 Jan 15; 13(2):159-70.
    View in: PubMed
    Score: 0.034
  29. Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development. Curr Neurol Neurosci Rep. 2002 Sep; 2(5):457-64.
    View in: PubMed
    Score: 0.031
  30. Combination of A? Suppression and Innate Immune Activation in the Brain Significantly Attenuates Amyloid Plaque Deposition. Am J Pathol. 2017 Dec; 187(12):2886-2894.
    View in: PubMed
    Score: 0.022
  31. Amyloid-? plaques disrupt axon initial segments. Exp Neurol. 2016 07; 281:93-8.
    View in: PubMed
    Score: 0.020
  32. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease. J Neurosci. 2016 Jan 13; 36(2):577-89.
    View in: PubMed
    Score: 0.020
  33. NF?B-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease. Neuron. 2015 Jan 07; 85(1):101-115.
    View in: PubMed
    Score: 0.018
  34. Cerebral vascular leak in a mouse model of amyloid neuropathology. J Cereb Blood Flow Metab. 2014 Oct; 34(10):1646-54.
    View in: PubMed
    Score: 0.018
  35. Genetic modulation of soluble A? rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease. J Neurosci. 2014 Jun 04; 34(23):7871-85.
    View in: PubMed
    Score: 0.018
  36. Neuronal aggregates are associated with phenotypic onset in the R6/2 Huntington's disease transgenic mouse. Behav Brain Res. 2012 Apr 15; 229(2):308-19.
    View in: PubMed
    Score: 0.015
  37. Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. Hum Mol Genet. 2001 Oct 15; 10(22):2525-37.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.